EMA Withdrawn: Zoledronic acid Teva Generics (zoledronic acid monohydrate) — Teva Generics B.V

View source ↗

Summary

Withdrawn EMA entry for zoledronic acid Teva Generics (zoledronic acid monohydrate) with therapeutic use in osteoporosis and osteitis deformans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteitis Deformans
• Osteoporosis

Drugs mentioned

• Zoledronic acid Teva Generics (zoledronic acid monohydrate)

Snippet

Status: Withdrawn. Therapeutic area: Osteoporosis;Osteitis Deformans. MAH: Teva Generics B.V. Decision date: 13/07/2015